Skip to main content
. 2012 Jul 10;22(12):2699–2709. doi: 10.1007/s00330-012-2554-7

Table 4.

Impact of criteria

 Criteria met Sensitivity 95 % CI Specificity 95 % CI PPV NPV
Single criteria
 1. Percentage LV- MMnon-compacted > 25 % 91 62.3–98.4 100 92.1–100 100 98
(10/11) (45/45) (10/10) (45/46)
 2. Total LV-MMInon-compacted > 15 g/m2 91 62.3–98.4 91 79.3–96.5 71 98
(10/11) (41/45) (10/14) (41/42)
 3. Cut-off ≥ 3:1 (segment 17 excluded) 100 75.8–100 93 82.1–97.7 80 100
(12/12) (42/45) (12/15) (42/42)
 4. Trabeculation in segments 4–6 ≥ 2:1 67 39.1–86.2 91 79.3–96.5 67 91
(8/12) (41/45) (8/12) (41/45)
  Cut-off ≥ 3:1 (segment 17 included) 100 75.8–100 73 59.0–84.1 50 100
(12/12) (33/45) (12/24) (33/33)
  Cut-off > 2.3:1 (segment 17 excluded) 100 75.8–100 80 66.2–89.1 57 100
(12/12) (36/45) (12/21) (36/36)
  Cut-off > 2.3:1 (segment 17 included) 100 75.8–100 58 43.3–71.0 39 100
(12/12) (26/45) (12/31) (19/19)
Combined criteria (1–4)
 Two of four criteria (1–4) 100 75.8–100 95 85.2–98.8 86 100
(12/12) (43/45) (12/14) (43/43)
 Three of four criteria (1–4) 92 64.6–98.5 100 92.1–100 100 96
(11/12) (45/45) (9/9) (45/48)
 Four of four criteria (1–4) 75 46.8–91.1 100 92.1–100 100 94
(9/12) (45/45) (7/7) (45/49)

Sensitivity and specificity data are presented as percentage with number of related patients in parenthesis

CI confidence interval, PPV positive predictive value, NPV negative predictive value